HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Min Wei Selected Research

4- (4- cyclohexyl- 2- methyloxazol- 5- yl)- 2- fluorobenzenesulfonamide

1/2005JTE-522, a selective cyclooxygenase-2 inhibitor, inhibits induction but not growth and invasion of 1,2-dimethylhydrazine-induced tubular adenocarcinomas of colon in rats.
7/2004Inhibition of azoxymethane-induced colon carcinogenesis in rats due to JTE-522, a selective cyclooxygenase-2 inhibitor.
12/2003Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine-induced rat colon carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Min Wei Research Topics

Disease

142Neoplasms (Cancer)
06/2022 - 08/2002
35Carcinogenesis
05/2022 - 08/2002
19Breast Neoplasms (Breast Cancer)
06/2022 - 08/2011
13Infections
01/2022 - 09/2007
13Body Weight (Weight, Body)
04/2020 - 09/2002
12Melanoma (Melanoma, Malignant)
10/2018 - 11/2005
11Pain (Aches)
05/2022 - 08/2007
11Neoplasm Metastasis (Metastasis)
01/2021 - 07/2004
9Wounds and Injuries (Trauma)
01/2022 - 02/2002
9Prostatic Neoplasms (Prostate Cancer)
01/2020 - 05/2012
9Carcinoma (Carcinomatosis)
10/2014 - 01/2003
8Starvation
10/2016 - 06/2008
7Inflammation (Inflammations)
05/2022 - 12/2005
7Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 11/2004
7Alzheimer Disease (Alzheimer's Disease)
01/2021 - 05/2002
7Urinary Bladder Neoplasms (Bladder Cancer)
01/2017 - 01/2003
6Cognitive Dysfunction
05/2022 - 01/2009
6Hemorrhage
03/2022 - 08/2007
6Congenital Abnormalities (Deformity)
02/2022 - 09/2003
6COVID-19
01/2022 - 07/2020
6Stomach Neoplasms (Stomach Cancer)
12/2020 - 06/2010
6Glioma (Gliomas)
10/2020 - 06/2008
6Adenocarcinoma
03/2018 - 01/2005
6Hyperplasia
09/2013 - 08/2002
5Hyperlipidemias (Hyperlipidemia)
03/2022 - 10/2004
5Hypoxia (Hypoxemia)
10/2021 - 03/2014
5Adenocarcinoma of Lung
07/2020 - 01/2012
5Hypertelorism
03/2020 - 09/2003
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 04/2006
5Leukemia
01/2019 - 03/2003
4Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2022 - 01/2016
4Stress Fractures (Stress Fracture)
02/2022 - 05/2011
4Insulin Resistance
01/2022 - 02/2011
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 08/2007
4Acquired Immunodeficiency Syndrome (AIDS)
07/2021 - 06/2003
4Hepatocellular Carcinoma (Hepatoma)
03/2021 - 07/2009
4Colonic Neoplasms (Colon Cancer)
01/2021 - 12/2003
4Stroke (Strokes)
01/2020 - 02/2011
4Proteinuria
06/2019 - 12/2015
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019 - 01/2013
4Lung Neoplasms (Lung Cancer)
01/2017 - 08/2004
4Diabetic Nephropathies (Diabetic Nephropathy)
05/2012 - 12/2006
3Genomic Instability
06/2022 - 08/2009
3Type 2 Diabetes Mellitus (MODY)
01/2022 - 03/2011
3Ascites
12/2021 - 02/2021

Drug/Important Bio-Agent (IBA)

41Proteins (Proteins, Gene)FDA Link
05/2022 - 02/2002
18Biomarkers (Surrogate Marker)IBA
01/2019 - 03/2009
16Pharmaceutical PreparationsIBA
12/2021 - 03/2003
12Glucose (Dextrose)FDA LinkGeneric
01/2021 - 06/2008
12Messenger RNA (mRNA)IBA
01/2020 - 08/2003
12CarcinogensIBA
03/2011 - 10/2002
11Long Noncoding RNAIBA
01/2022 - 05/2012
10EnzymesIBA
06/2022 - 01/2005
9DNA (Deoxyribonucleic Acid)IBA
06/2022 - 08/2004
7Insulin (Novolin)FDA Link
01/2020 - 02/2011
7MicroRNAs (MicroRNA)IBA
12/2018 - 07/2012
7Glutathione Transferase (Glutathione S-Transferase)IBA
01/2011 - 08/2003
6RNA (Ribonucleic Acid)IBA
01/2020 - 06/2010
6SolutionsIBA
04/2017 - 01/2002
6Diethylnitrosamine (N-Nitrosodiethylamine)IBA
11/2013 - 01/2006
5Reactive Oxygen Species (Oxygen Radicals)IBA
08/2022 - 08/2002
5Therapeutic UsesIBA
05/2022 - 08/2007
5Immunoglobulin G (IgG)IBA
05/2022 - 01/2018
5Indicators and Reagents (Reagents)IBA
01/2022 - 07/2009
5Tumor Biomarkers (Tumor Markers)IBA
03/2020 - 12/2009
5LipidsIBA
02/2019 - 09/2002
5AntigensIBA
01/2018 - 03/2011
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017 - 09/2002
5Insulin-Like Growth Factor I (IGF-1)IBA
03/2014 - 09/2002
5Heparin (Liquaemin)FDA LinkGeneric
02/2012 - 07/2004
5ArsenicIBA
06/2006 - 08/2002
4AcidsIBA
06/2022 - 10/2007
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2022 - 01/2007
4AntibodiesIBA
05/2022 - 09/2009
4VaccinesIBA
11/2021 - 06/2003
4GlycogenIBA
09/2021 - 02/2005
4Phenobarbital (Luminal)FDA Link
01/2021 - 07/2009
4Hormones (Hormone)IBA
12/2020 - 01/2009
4Telomerase (Telomerase Reverse Transcriptase)IBA
11/2017 - 01/2016
4ProteomeIBA
07/2012 - 07/2009
4P-SelectinIBA
01/2010 - 07/2004
3MetalsIBA
07/2022 - 09/2016
3Tretinoin (Retinoic Acid)FDA LinkGeneric
05/2022 - 01/2007
3Uric Acid (Urate)IBA
01/2022 - 04/2009
3Immunoglobulins (Immunoglobulin)IBA
01/2022 - 03/2020
3Neutralizing AntibodiesIBA
01/2022 - 04/2011
3Immune Checkpoint InhibitorsIBA
12/2021 - 10/2020

Therapy/Procedure

49Therapeutics
06/2022 - 03/2004
15Drug Therapy (Chemotherapy)
12/2020 - 06/2008
13Debridement
03/2022 - 04/2010
8Osteotomy
03/2020 - 09/2003
5Radiotherapy
01/2021 - 01/2012
5Precision Medicine
12/2020 - 04/2018
5Lasers (Laser)
12/2018 - 07/2009
5Synovectomy
03/2017 - 08/2007
4Chemoradiotherapy
06/2022 - 05/2018
4Immunotherapy
01/2022 - 01/2020
4Sutures (Suture)
11/2021 - 08/2011
4Arthroscopes
08/2011 - 03/2007
3Intraperitoneal Injections
12/2021 - 11/2017